JPMorgan Chase & Co’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$163K Sell
25,603
-188,144
-88% -$1.2M ﹤0.01% 4559
2025
Q1
$1.04M Buy
213,747
+213,313
+49,150% +$1.04M ﹤0.01% 3645
2024
Q4
$4.15K Sell
434
-209
-33% -$2K ﹤0.01% 5495
2024
Q3
$5.37K Sell
643
-648,859
-100% -$5.42M ﹤0.01% 5410
2024
Q2
$4.43M Buy
649,502
+375,962
+137% +$2.56M ﹤0.01% 2595
2024
Q1
$692K Buy
273,540
+222,583
+437% +$563K ﹤0.01% 3776
2023
Q4
$122K Sell
50,957
-242
-0.5% -$581 ﹤0.01% 4685
2023
Q3
$174K Buy
51,199
+7,859
+18% +$26.7K ﹤0.01% 4308
2023
Q2
$319K Sell
43,340
-26,721
-38% -$196K ﹤0.01% 4011
2023
Q1
$726K Sell
70,061
-174,182
-71% -$1.8M ﹤0.01% 3628
2022
Q4
$2.88M Buy
244,243
+181,213
+288% +$2.14M ﹤0.01% 2732
2022
Q3
$1.32M Sell
63,030
-104,184
-62% -$2.19M ﹤0.01% 3179
2022
Q2
$5.19M Buy
167,214
+8,421
+5% +$261K ﹤0.01% 2381
2022
Q1
$6.52M Buy
158,793
+110,909
+232% +$4.55M ﹤0.01% 2369
2021
Q4
$2.08M Sell
47,884
-47,003
-50% -$2.04M ﹤0.01% 3207
2021
Q3
$4.75M Sell
94,887
-4,657
-5% -$233K ﹤0.01% 2612
2021
Q2
$6.27M Sell
99,544
-3,537
-3% -$223K ﹤0.01% 2495
2021
Q1
$9.58M Sell
103,081
-78,735
-43% -$7.32M ﹤0.01% 2161
2020
Q4
$16.3M Sell
181,816
-9,278
-5% -$831K ﹤0.01% 1590
2020
Q3
$19.9M Buy
191,094
+142,592
+294% +$14.9M ﹤0.01% 1325
2020
Q2
$3.84M Buy
48,502
+25,745
+113% +$2.04M ﹤0.01% 2316
2020
Q1
$1.32M Sell
22,757
-586
-3% -$33.9K ﹤0.01% 2816
2019
Q4
$1.26M Buy
23,343
+255
+1% +$13.8K ﹤0.01% 2934
2019
Q3
$1.21M Sell
23,088
-250
-1% -$13.1K ﹤0.01% 2974
2019
Q2
$1.12M Buy
23,338
+1,272
+6% +$61K ﹤0.01% 3001
2019
Q1
$1.12M Sell
22,066
-21,923
-50% -$1.11M ﹤0.01% 2975
2018
Q4
$2.61M Buy
43,989
+17,210
+64% +$1.02M ﹤0.01% 2501
2018
Q3
$1.76M Buy
26,779
+4,980
+23% +$328K ﹤0.01% 2849
2018
Q2
$1.1M Sell
21,799
-35,146
-62% -$1.78M ﹤0.01% 3094
2018
Q1
$3M Sell
56,945
-22,210
-28% -$1.17M ﹤0.01% 2530
2017
Q4
$3.68M Buy
79,155
+65,667
+487% +$3.05M ﹤0.01% 2431
2017
Q3
$537K Sell
13,488
-187
-1% -$7.45K ﹤0.01% 3177
2017
Q2
$463K Buy
13,675
+442
+3% +$15K ﹤0.01% 3182
2017
Q1
$384K Buy
13,233
+257
+2% +$7.46K ﹤0.01% 3256
2016
Q4
$426K Sell
12,976
-65,724
-84% -$2.16M ﹤0.01% 3358
2016
Q3
$2.48M Buy
78,700
+64,327
+448% +$2.03M ﹤0.01% 2362
2016
Q2
$404K Buy
14,373
+548
+4% +$15.4K ﹤0.01% 3052
2016
Q1
$503K Sell
13,825
-6,791
-33% -$247K ﹤0.01% 2911
2015
Q4
$824K Sell
20,616
-4,137
-17% -$165K ﹤0.01% 2741
2015
Q3
$705K Sell
24,753
-923
-4% -$26.3K ﹤0.01% 2826
2015
Q2
$846K Buy
25,676
+3,176
+14% +$105K ﹤0.01% 2890
2015
Q1
$647K Sell
22,500
-200
-0.9% -$5.75K ﹤0.01% 3002
2014
Q4
$618K Sell
22,700
-1,716
-7% -$46.7K ﹤0.01% 2958
2014
Q3
$520K Buy
24,416
+1,312
+6% +$27.9K ﹤0.01% 2997
2014
Q2
$520K Buy
23,104
+4,450
+24% +$100K ﹤0.01% 3025
2014
Q1
$472K Buy
+18,654
New +$472K ﹤0.01% 3077
2013
Q4
Sell
-53,620
Closed -$1.02M 3652
2013
Q3
$1.02M Buy
53,620
+11,397
+27% +$217K ﹤0.01% 2986
2013
Q2
$609K Buy
+42,223
New +$609K ﹤0.01% 3135